17
Views
2
CrossRef citations to date
0
Altmetric
Research Article

The Sedimentable Sterols in Gallstone Patients before and during Ursodeoxycholic Acid and Simvastatin Treatments

Pages 1297-1302 | Published online: 08 Jul 2009

References

  • Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WJ. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979;77:611–7.
  • Lee SP, Nicholls JF. Nature and composition of biliary sludge. Gastroenterology 1986;90:677–86.
  • Miettinen TA, Kesäniemi YA, Järvinen H, Hästbacka J. Cholesterol precursor sterols, plant sterols, and cholestanol in human bile and gallstones. Gastroenterology 1986;90:858–64.
  • Miettinen TA. Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci 1969;8:713–21.
  • Vuoristo M, Miettinen TA. Serum cholesterol precursor sterols in coeliac disease: effects of glutein free diet and cholestyramine. Gut 1986;27:1312–9.
  • Tilvis R, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr 1986;43:92–7.
  • Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in random male population. Am J Epidemiol 1990; 131:20–31.
  • Miettinen TE, Kesäniemi YA, Gylling H, Järvinen H, Silven-noinen E, Miettinen TA. Noncholesterol sterols in bile and stones of patients with cholesterol and pigment stones. Hepatology 1996;23:274–80.
  • Nilsell K, Angelin B, Leijd B, Einarsson K. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Gastroenterology 1983;85:1248–56.
  • von Bergmann K, Epple-Gutsfeld M, Leiss O. Differences in the effects of chenodeoxycholic acid and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. Gastroenterology 1984;87:136–43.
  • Hoogerbrugge-vd Linden N, de Rooy FWM, Jansen H, van Blankenstein M. Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia. Gut 1990;31:348–50.
  • Okamoto S, Nakano K, Kosahara K, Kishinaka M, Oda H, Icgimiya H, et al. Effects of pravastatin and ursodeoxycholic acid on cholesterol and bile acid metabolism in patients with cholesterol gallstones. J Gastroenterol 1994;29:47–55.
  • Smit JWA, Van Erpecum KJ, Portincasa P, Renooij W, Erkelens DW, van Berge-Henegouven GP. Effects of simvastatin and cholestyramine on bile lipid composition and gallbladder motility in patients with hypercholesterolemia. Gut 1995;37: 654–9.
  • Portincasa P, van Erpecum KJ, Jansen A, Renooij W, Gadellaa M, van Berge-Henegouwen GP. Behaviour of various cholesterol crystals in bile from patients with gallstones. Hepatology 1996;23:738–48.
  • Sahlin S, Thyberg P, Ahlberg J, Angelin B, Einarsson K. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with cheno-deoxycholic acid and ursodeoxycholic acid. Hepatology 1991; 13:104–10.
  • Miettinen TE, Kiviluoto T, Taavitsainen M, Miettinen TA, Vuoristo M. Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. Hepatology 1998;27:649–55.
  • Rishlau P, Bernt E, Gruber W. Enzymatische bestimmung des gesamt cholesterius in serum. Z Klin Biochem 1974;12:403–7.
  • Wahleweld AW. Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HU, editor. Methods in enzymatic analysis. Vol. 5. New York: Academic Press; 1974. p. 1831–5.
  • Miettinen TA, Koivisto P. Noncholesterol sterols and bile acid production in hypercholesterolemic patients with ileal bypass. In: Paumgartner G, Stiehl A, Gerok W. Bile acids in health and disease. Lancaster: MTP; 1983. p. 183–7.
  • Miettinen TA. Cholesterol treatment during ketoconazole treatment in man. J Lipid Res 1988;29:43–51.
  • Bartlett GR. Phosphorous assay in column chromatogaphy. J Biol Chem 1959;234:466–8.
  • Thomas PJ, Hofmann AF. A simple calculation of the lithogenic index of the bile. Gastroenterology 1973;65:698–700.
  • Carey MC, Ko G. The importance of total lipid concentration in determining cholesterol solubility in bile and the development of critical tables for calculating ‘percent cholesterol saturation’ with correction factor for ursodeoxycholate-rich bile. In: Paumgartner G, Stiehl A, Gerok W. Biological effects of bile acids. Lancaster: MTP Press; 1979. p. 299–308.
  • Dixon WJ, BMDP Statistical software. Los Angeles: University of California Press; 1981.
  • Choudhuri G, Agarwal DK, Saraswat VA, Negi TS, Saxena R, Kapoor VK. Is duodenal bile representative of gallbaldder bile? Scand J Gastroenterol 1993;28:920–3.
  • Janowitz P, Swobodnik W, Wechsler JG, Zoller A, Kuhn K, Ditschuneit H. Comparison of gall bladder bile and endoscopically obtained duodenal bile. Gut 1990;31:1407–10.
  • Jungst D, del Pozo R, Christoph S, Miquel JF, Eder MI, Lange V, et al. Sedimentation of biliary ‘sludge’. Effect on composition of gallbladder bile from patients with cholesterol, mixed, or pigment stones. Scand J Gastroenterol 1996;31:273–8.
  • Miettinen TE, Tarpila S, Gylling H. The effect of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones. Hepatology 1997;25:514–8.
  • Bennion LJ, Grundy SM. Risk factors for the development of cholelithiasis in man. I and II. N Engl J Med 1978;299:1221–7, 1161–7.
  • Miettinen TA. Cholesterol production in obesity. Circulation 1971;44:842–50.
  • Bennion LJ, Grundy SM. Effects of obesity and caloric intake on biliary lipid metabolism in man. J Clin Invest 1975;56:996–1011.
  • Grundy SM, Duane WC, Adler RD. Biliary lipid outputs in young women with cholesterol gallstones. Metabolism 1974; 23:67–73.
  • Miettinen TA. Regulation of serum cholesterol by cholesterol absorption. In: Parnham MJ, Niemann R, editors. Cologne atherosclerosis conference no.4: cholesterol homeostatis. Cologne: Birkhauser; 1988. p. 53–65.
  • O’Donnel LDJ, Heaton KW. Recurrence and re-recurrence of gallstones after medical dissolution: a long-term follow-up. Gut 1988;29:655–8.
  • Smit JWA, van Erpecum KJ, van Berge-Henegouwen GP. Cholesterol synthesis inhibitors in cholesterol gallstone disease. Scand J Gastroenterol 1996;31 Suppl 218:56–60.
  • Vanhanen HT, Miettinen TA. Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. Atherosclerosis 1995;115:135–46.
  • Goldberg IJ, Holleran S, Ramakrishnan R, Adams M, Palmer RH, Dell RB, et al. Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism. J Clin Invest 1990;86:801–8.
  • Grundy SM, Bilheimer DW. Inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. Proc Natl Acad Sci USA 1984;81:2538–42.
  • Hillebrant CG, Nyberg B, Einarsson K, Eriksson M. The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans. Gut 1997;41:700–4.
  • Botham KM, Bravo E. The role of lipoprotein cholesterol in biliary steroid secretion. Studies with in vivo experimental models. Prog Lipid Res 1995;34:71–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.